previous  12345678910...  next  · entire list

Merck Suspends Lobbying for Vaccine
2007-02-21, CBS News/Associated Press
http://www.cbsnews.com/stories/2007/02/21/ap/business/mainD8NDU4AG0.shtml

Pediatricians, gynecologists and even health insurers all call Gardasil, the first vaccine to prevent cervical cancer, a big medical advance. But medical groups, politicians and parents began rebelling after disclosure of a behind-the-scenes lobbying campaign by Gardasil's maker, Merck & Co., to get state legislatures to require 11- and 12-year-old girls to get the three-dose vaccine as a requirement for school attendance. Some parents' groups and doctors particularly objected because the vaccine protects against a sexually transmitted disease. Vaccines mandated for school attendance usually are for diseases easily spread through casual contact, such as measles and mumps. Bowing to pressure, Merck said Tuesday that it is immediately suspending its controversial campaign, which it had funded through a third party. Legislatures in roughly 20 states have introduced measures that would mandate girls have the vaccine to attend school. Texas Gov. Rick Perry on Feb. 2 issued an executive order requiring Texas girls entering the sixth grade as of 2008 get the vaccinations. Dr. Anne Francis, who chairs an American Academy of Pediatrics committee [stated] "I believe that their timing was a little bit premature," she said, "so soon after (Gardasil's) release, before we have a picture of whether there are going to be any untoward side effects." The country has been "burned" by some drugs whose serious side effects emerged only after they were in wide use, including Merck's withdrawn painkiller Vioxx. The vaccine also is controversial because of its price - $360 for the three doses required.

Note: $360 for every girl in school would amount to quite a hefty transfer of funds from taxpayers into the pockets of Merck. Could profit and campaign contributions be behind the move to make this mandatory?

Scientists find way to slash cost of drugs
2007-01-02, The Guardian (One of the U.K.'s leading newspapers)
http://www.guardian.co.uk/india/story/0,,1981200,00.html

Two UK-based academics have devised a way to invent new medicines and get them to market at a fraction of the cost charged by big drug companies. Sunil Shaunak, professor of infectious diseases at Imperial College ... calls their revolutionary new model "ethical pharmaceuticals". Improvements they devise to the molecular structure of an existing, expensive drug turn it technically into a new medicine which is no longer under a 20-year patent to a multinational drug company and can be made and sold cheaply. The process has the potential to undermine the monopoly of the big drug companies and bring cheaper drugs not only to poor countries but back to the UK. Professor Shaunak and his colleague from the London School of Pharmacy, Steve Brocchini, have linked up with an Indian biotech company which will manufacture the first drug - for hepatitis C. Hepatitis C affects 170 million people worldwide and at least 200,000 in the UK. Multinational drug companies put the cost of the research and development of a new drug at $800m (£408m). Professors Shaunak and Brocchini say the cost of theirs will be only a few million pounds. Professor Shaunak says it is time that the monopoly on drug invention and production by multinational corporations - which charge high prices because they need to make big profits for their shareholders - was broken. The team's work on the hepatitis C drug has impeccable establishment credentials. But the professors' ethical pharmaceutical model is unlikely to find much favour with the multinational pharmaceutical companies, which already employ large teams of lawyers to defend the patents which they describe as the lifeblood of the industry.

Note: This is very exciting news, but we'll see what happens when the hugely profitable pharmaceutical industry presses its might against this effort. For more, click here.

Has Politics Contaminated the Food Supply?
2006-12-11, New York Times
http://www.nytimes.com/2006/12/11/opinion/11schlosser.html?ex=1323493200&en=4...

One hundred years ago, companies were free to follow their own rules. The publication of Upton Sinclair’s novel “The Jungle” in 1906 — with its descriptions of rat-infested slaughterhouses and rancid meat — created public outrage over food safety. Even though the book was written by a socialist agitator, a Republican president, Theodore Roosevelt, eagerly read it. After confirming Sinclair’s claims, Roosevelt battled the drug companies, the big food processors and the meatpacking companies to protect American consumers from irresponsible corporate behavior. Over the past 40 years, the industrialization and centralization of our food system has greatly magnified the potential for big outbreaks. As a result, a little contamination can go a long way. The Taco Bell distribution center in New Jersey now being investigated as a possible source of E. coli supplies more than 1,100 restaurants in the Northeast. Since 2000, the fast-food and meatpacking industries have given about four-fifths of their political donations to Republican candidates for national office. In return, these industries have effectively been given control of the agencies created to regulate them. The current chief of staff at the Agriculture Department used to be the beef industry’s chief lobbyist. The person who headed the Food and Drug Administration until recently used to be an executive at the National Food Processors Association. Cutbacks in staff and budgets have reduced the number of food-safety inspections conducted by the F.D.A. to about 3,400 a year — from 35,000 in the 1970s.

Note: If you care about the health of our nation's food supply, write your political and media representatives encouraging the passage of the Safe Food Act mentioned in this article, which by the way, was written by the author of the most excellent book, Fast Food America.

Genetically Engineered Rice Wins USDA Approval
2006-11-25, Washington Post
http://www.washingtonpost.com/wp-dyn/content/article/2006/11/24/AR20061124011...

The Department of Agriculture declared safe for human consumption yesterday an experimental variety of genetically engineered rice found to have contaminated the U.S. rice supply this summer. The move ... to deregulate the special long-grain rice, LL601, was seen as a legal boon to its creator, Bayer CropScience. The company applied for approval shortly after the widespread contamination was disclosed in August and now faces a class-action lawsuit filed by hundreds of farmers in Arkansas and Missouri. The experimental rice ... escaped from Bayer's test plots after the company dropped the project in 2001. The resulting contamination, once it became public, prompted countries around the world to block rice imports from the United States, sending rice futures plummeting and farmers into fits. In approving the rice, the USDA allowed Bayer to take a regulatory shortcut and skip many of the usual safety tests. Joseph Mendelson, legal director of the nonprofit Center for Food Safety, said the quick approval shows that the USDA is more concerned about the fortunes of the biotechnology industry than about consumers' health. "USDA is telling agricultural biotechnology companies that it doesn't matter if you're negligent, if you break the rules, if you contaminate the food supply with untested genetically engineered crops, we'll bail you out," Mendelson said in a statement. Officials in Europe, where genetically altered rice is derisively dubbed "Frankenfood," made clear as recently as last week that European countries will not accept any U.S. rice, he said.

Note: For reliable information on the deception and dangers of GM (Genetically Modified) food, click here.

Big Tobacco Lied to Public, Judge Says
2006-08-18, Washington Post
http://www.washingtonpost.com/wp-dyn/content/article/2006/08/17/AR20060817007...

A federal judge ruled yesterday that tobacco companies have violated civil racketeering laws, concluding that cigarette makers conspired for decades to deceive the public about the dangers of their product. But U.S. District Judge Gladys Kessler said that under a 2005 appellate court ruling, she could not impose billions of dollars in penalties that had been sought by the Justice Department in its civil racketeering suit. In the opinion...Kessler wrote that there is "overwhelming evidence" [that the industry] conspired to violate, and indeed violated, federal racketeering laws. "In short," she wrote, "defendants have marketed and sold their lethal product with zeal, with deception, with a single-minded focus on their financial success, and without regard for the human tragedy or social costs that success exacted. Over the course of more than 50 years, defendants lied, misrepresented and deceived the American public, including smokers and the young people...about the devastating health effects of smoking and environmental tobacco smoke." Kessler added that the companies "suppressed research, they destroyed documents, they manipulated the use of nicotine so as to increase and perpetuate addiction...and they abused the legal system in order to achieve their goal -- to make money." The Justice Department lawsuit originally sought $280 billion. But the U.S. Court of Appeals [ruled] a company could not be forced to turn over past profits as a way of preventing future misconduct. The Justice Department subsequently proposed a $130 billion penalty to pay for anti-smoking programs, but...it scaled that back to a total of $14 billion.

Sickened Iraq Vets Cite Depleted Uranium
2006-08-13, ABC News/Associated Press
http://abcnews.go.com/US/wireStory?id=2307268

A shell coated with depleted uranium pierces a tank like a hot knife through butter. It also leaves behind a fine radioactive dust with a half-life of 4.5 billion years. Depleted uranium is the garbage left from producing enriched uranium for nuclear weapons and energy plants. At Walter Reed Army Medical Center in Washington, D.C., [Herbert Reed] ran into a buddy from his unit. And another, and another. They began to talk. [They] all have depleted uranium in their urine. The veterans, using their positive results as evidence, have sued the U.S. Army, claiming officials knew the hazards of depleted uranium, but concealed the risks. The Department of Defense says depleted uranium is powerful and safe. Military research on mice shows that depleted uranium can enter the bloodstream and come to rest in bones, the brain, kidneys and lymph nodes. Other research in rats shows that DU can result in cancerous tumors and genetic mutations. Fifteen years after it was first used in battle, there is only one U.S. government study monitoring veterans exposed to depleted uranium. Number of soldiers in the survey: 32. Depleted uranium falls into the quagmire of Gulf War Syndrome, from which no treatment has emerged. About 30 percent of the 700,000 men and women who served in the first Gulf War still suffer [this] baffling array of symptoms. Depleted uranium has long been suspected as a possible contributor. It took more than 25 years for the Pentagon to acknowledge that Agent Orange...was linked to [major disease and] sufferings. It took 40 years for the military to compensate sick World War II vets exposed to massive blasts of radiation during tests of the atomic bomb.

Note: Why isn't the media reporting more on this health disaster? For lots more on how veterans suffer from corporate and governmental denial and manipulations, see what a highly decorated U.S. General has to say on the suffering of soldiers at http://www.WantToKnow.info/warcoverup. For an amazingly revealing documentary with interviews from top sources on the depleted uranium cover-up, click here.

Vitamin C: Cancer cure?
2006-06-18, Philadelphia Inquirer (Philadelphia's leading newspaper)
http://www.philly.com/mld/inquirer/living/health/14842932.htm

Government nutrition researcher [Dr. Mark Levine] has published new evidence that suggests vitamin C can work like chemotherapy - only better. But so far, he hasn't been able to interest cancer experts in conducting the kind of conclusive studies that, one way or the other, would advance treatment. "If vitamin C is useful in cancer treatment, that's wonderful. If it's not, or if it's harmful, that's fine, too," said Levine, a Harvard-educated physician at the National Institute of Diabetes and Digestive and Kidney Diseases. The distinction between oral and intravenous is crucial. The body automatically gets rid of extra C through urine. Levine's lab has shown that, at high concentrations, the vitamin is toxic to many types of cancer cells in lab dishes. But to get that much C into the body before it's eliminated, it must be put directly into the blood. Five out of nine types of cancer cells that were put in simulated body-cavity fluid died when concentrated ascorbate or peroxide was added to the dish. And the best part: This same lethal marinade had no effect on healthy cells. "Interest is definitely growing," said Kenneth Bock, physician and president of the American College for Advancement in Medicine, an alternative-medicine society that teaches ascorbate infusion protocols. The American Cancer Society and the American Association of Clinical Oncologists warn patients against high-dose C, as do leading cancer centers such as the University of Pennsylvania's and Memorial Sloan-Kettering.

Note: If the above link does not work, the article is also available on the website of the San Diego Union-Tribune. For why this is not making major headlines in the news, click here and here.

Donald Rumsfeld makes $5m killing on bird flu drug
2006-03-12, Independent (one of the UK's leading newspapers)
http://news.independent.co.uk/world/americas/article350787.ece

The US Defence Secretary has made more than $5m (£2.9m) in capital gains from selling shares in the biotechnology firm that discovered and developed Tamiflu, the drug being bought in massive amounts by Governments to treat a possible human pandemic of the disease. More than 60 countries have so far ordered large stocks of the antiviral medication - the only oral medicine believed to be effective against the deadly H5N1 strain of the disease - to try to protect their people. The United Nations estimates that a pandemic could kill 150 million people worldwide. The drug was developed by a Californian biotech company, Gilead Sciences. Mr Rumsfeld was on the board of Gilead from 1988 to 2001, and was its chairman from 1997. He then left to join the Bush administration, but retained a huge shareholding. The 2005 report showed that, in all, he owned shares worth up to $95.9m, from which he got an income of up to $13m. The firm made a loss in 2003, the year before concern about bird flu started. Then revenues from Tamiflu almost quadrupled, to $44.6m, helping put the company well into the black. Sales almost quadrupled again, to $161.6m last year.

Note: If the above link fails, click here. For many more strange coincidences and facts around the avian flu scare, take a look at our summary of eye-opening news articles available here.

AIDS Drug Maker to Pay $704M in Settlement
2005-10-17, ABC/Associated Press
http://abcnews.go.com/Business/wireStory?id=1223871

Serono Laboratories agreed Monday to pay $704 million and plead guilty to federal conspiracy charges that it increased the market for the AIDS drug Serostim by offering kickbacks to doctors and manipulating a test for AIDS patients. Eighty-five percent of prescriptions written for Serostim, accounting for roughly $615 million in sales, were unnecessary. The cost of many of those prescriptions, $21,000 for 12 weeks of treatment, was paid by Medicaid, the joint federal-state health program for the poor, and other government insurance plans. Serono offered doctors free trips to the south of France in return for agreeing to write up to 30 new prescriptions for Serostim. The company also conspired to introduce a test for AIDS wasting, despite not having FDA approval. The test diagnosed AIDS wasting even without weight loss. Monday's settlement is the latest in a series of whistleblower claims that have resulted in more than $3 billion in payments from drug companies in recent years.

Note: For lots more on this vital topic: http://www.WantToKnow.info/healthcoverup

'The Future of Food'
2005-09-30, San Francisco Chronicle (San Francisco's leading newspaper)
http://www.sfgate.com/cgi-bin/article.cgi?f=/c/a/2005/09/30/DDGHOEVICB1.DTL#f...

Food insiders may already know the disturbing facts highlighted by this film, but the general public is in for a shock at how corporations are using misleading campaigns -- and scare tactics -- to ensure that people around the world become dependent on genetically modified food. Monsanto and other corporate behemoths are motivated (not surprisingly) by profits, according to farmers, academics and others who talk to documentarian Deborah Koons Garcia. Canadian farmer Percy Schmeiser was targeted by Monsanto's lawyers because some of the corporation's patented seedlings were found on his property. Schmeiser didn't plant them there; wind blew the insecticide-resistant seeds onto his farm from another farm, or the seeds fell off a passing truck. Monsanto didn't care, ordering Schmeiser to kill all his family's seed because they'd potentially been contaminated by its patented product. Schmeiser ... fought Monsanto, spending his retirement money against the sort of legal attack that has already scared farmers throughout North America. Incredibly, a judge ruled in favor of Monsanto. Garcia's documentary shows how much the U.S. federal government favors these corporations, especially through lax oversight (the [FDA] and the Department of Agriculture seem to rubber-stamp every corporate project having to do with genetically modified food). In the past 20 years, Monsanto's alumni have occupied the high reaches of American power. Supreme Court Justice Clarence Thomas, for example, did legal work for the corporation, while Secretary of Defense Donald Rumsfeld was president of a Monsanto subsidiary.

Note: To view this highly educational film, click here. To read another excellent review of this important documentary, click here.

Deadly Immunity - by Robert F. Kennedy, Jr.
2005-06-16, Common Dreams/Boston Globe
http://www.commondreams.org/views05/0616-31.htm

In June 2000, a group of top government scientists and health officials gathered for a meeting at the isolated Simpsonwood conference center...to ensure complete secrecy. The federal officials and industry representatives had assembled to discuss a disturbing new study that raised alarming questions about the safety of a host of common childhood vaccines administered to infants and young children. A mercury-based preservative in the vaccines -- thimerosal -- appeared to be responsible for a dramatic increase in autism. But instead of taking immediate steps to alert the public and rid the vaccine supply of thimerosal, the officials and executives at Simpsonwood spent most of the next two days discussing how to cover up the damaging data. According to transcripts obtained under the Freedom of Information Act, many at the meeting were concerned about how the damaging revelations about thimerosal would affect the vaccine industry's bottom line. The CDC paid the Institute of Medicine to conduct a new study to whitewash the risks of thimerosal, ordering researchers to "rule out" the chemical's link to autism. Senate Majority Leader Bill Frist, who has received $873,000 in contributions from the pharmaceutical industry, has been working to immunize vaccine makers from liability in 4,200 lawsuits that have been filed by the parents of injured children. More than 500,000 kids currently suffer from autism. The disease was unknown until 1943, when it was identified and diagnosed among 11 children born in the months after thimerosal was first added to baby vaccines in 1931. Internal documents reveal that Eli Lilly, which first developed thimerosal, knew from the start that its product could cause damage -- and even death -- in both animals and humans.

Note: A good, though somewhat watered down version of the above article was published in the Boston Globe on July 1, 2005. To see this article on the Globe website, click here.

A child's return from autism
2005-05-25, San Francisco Chronicle (San Francisco's leading newspaper)
http://sfgate.com/cgi-bin/article.cgi?f=/c/a/2005/05/25/BAGU0CU2K71.DTL

A Lafayette couple, certain that chelation therapy has helped their autistic son, stepped squarely into the controversy surrounding the causes of autism and its treatment Tuesday as they joined 150 other parents in launching an international support group that will aggressively promote the treatment. The Handleys are now among a small minority of parents -- who, believing that the autism was caused by the mercury in thimerosal, a preservative that was routinely used in vaccines until recently -- are treating their children with chelation therapy, a lotion or pill that strips the body of heavy metals. It has been used for decades to detoxify people contaminated in industrial accidents, but no studies have proved whether it is an effective treatment for autism. For Jamie's parents, the proof they need is in front of them: Jamie, now 3 years old and several months into treatment, is plump and playing baseball. His smile has returned. The Handleys said the new support group, Generation Rescue, www.generationrescue.com, will offer information on chelation therapy and connect parents with those who can help.

Note: For why the some powerful people may be covering up this important information, click here.

Of Mice, Men and In-Between
2004-11-20, Washington Post
http://www.washingtonpost.com/ac2/wp-dyn/A63731-2004Nov19

In Minnesota, pigs are being born with human blood in their veins. In Nevada, there are sheep whose livers and hearts are largely human. In California, mice peer from their cages with human brain cells firing inside their skulls. Biologists call these hybrid animals chimeras, after the mythical Greek creature with a lion's head, a goat's body and a serpent's tail. Chimeras are allowing scientists to watch, for the first time, how nascent human cells and organs mature and interact ... inside the bodies of living creatures. But with no federal guidelines in place ... how human must a chimera be before more stringent research rules should kick in? Chimerism becomes a more sensitive topic when it involves growing entire human organs inside animals. And it becomes especially sensitive when it deals in brain cells. Imagine, said Robert Streiffer, a professor of philosophy and bioethics at the University of Wisconsin, a human-chimpanzee chimera endowed with speech ... what some have called a "humanzee." Perhaps the most ambitious efforts to make use of chimeras come from Irving Weissman, director of Stanford University's Institute of Cancer/Stem Cell Biology and Medicine. Weissman helped make the first mouse with a nearly complete human immune system. More recently his team injected human neural stem cells into mouse fetuses, creating mice whose brains are about 1 percent human. Now Weissman says he is thinking about making chimeric mice whose brains are 100 percent human.

Note: If the above link fails, click here.

Biotech critics at risk : Economics calls the shots in the debate
2004-01-11, San Francisco Chronicle (San Francisco's leading newspaper)
http://sfgate.com/cgi-bin/article.cgi?file=/chronicle/archive/2004/01/11/INGH...

Between 1999 and 2001, unbeknownst to the others, each [of four scientists] made a simple but dramatic discovery that challenged the catechism of the same powerful industry -- biotechnology -- that by then had become the handmaiden of industrial agriculture and the darling of venture capitalists. When he was the principal scientific officer of the Rowett Institute in Aberdeen, Scotland, Hungarian citizen Arpad Pusztai fed transgenically modified [GMO] potatoes to rodents in one of the few experiments that have ever tested the safety of genetically modified food. Almost immediately, the rats displayed tissue and immunological damage. After he reported his findings, which eventually underwent peer review and were published in the United Kingdom's leading medical journal, Lancet, Pusztai's home was burglarized and his research files taken. Soon thereafter, he was fired from his job at Rowett, and he has since suffered an orchestrated international campaign of discreditation. [Read full article for the other three distrubing stories of scientific suppression] These four men were not attacked because of flawed or imperfect experiments but because the findings of their work have a potential economic effect. The sad part is that the academies and other allegedly independent institutions that once defended scientific freedom and protected employees like Hayes, Chapela, Losey and Pusztai are abandoning them to the wolves of commerce, the brands of which are being engraved over the entrances to a disturbing number of university labs.

Note: Big money is clearly stifling good science and keeping the public in the dark about genetic modifications in the food we eat. To educate yourself on this most important topic, click here.

The Man Behind The Vaccine Mystery
2002-12-12, CBS News
http://www.cbsnews.com/stories/2002/12/12/eveningnews/main532886.shtml

It's been a mystery in Washington for weeks. Just before President Bush signed the homeland security bill into law an unknown member of Congress inserted a provision into the legislation that blocks lawsuits against the maker of a controversial vaccine preservative called "thimerosal," used in vaccines that are given to children. Drug giant Eli Lilly and Company makes thimerosal. It's the mercury in the preservative that many parents say causes autism in thousands of children. But nobody in Congress would admit to adding the provision, reports CBS News Correspondent Jim Acosta – until now. House Majority Leader Dick Armey tells CBS News he did it to keep vaccine-makers from going out of business under the weight of mounting lawsuits. "I did it and I'm proud of it," says Armey, R-Texas. "It's a matter of national security," Armey says. Because Armey is retiring at the end of the year, some say the outgoing majority leader is the perfect fall guy to take the heat and shield the White House from embarrassment.

Note: Though this is old news, it is very important news showing how beholden the government is to the powerful drug companies.

Psychiatric Group Faces Scrutiny Over Drug Industry Ties
2008-07-12, New York Times
http://www.nytimes.com/2008/07/12/washington/12psych.html?partner=rssuserland...

It seemed an ideal marriage, a scientific partnership that would attack mental illness from all sides. Psychiatrists would bring ... their expertise and clinical experience, drug makers would provide their products and the money to run rigorous studies, and patients would get better medications, faster. But now the profession itself is under attack in Congress, accused of allowing this relationship to become too cozy. After a series of stinging investigations of individual doctors’ arrangements with drug makers, Senator Charles E. Grassley, Republican of Iowa, is demanding that the American Psychiatric Association, the field’s premier professional organization, give an accounting of its financing. "I have come to understand that money from the pharmaceutical industry can shape the practices of nonprofit organizations that purport to be independent in their viewpoints and actions," Mr. Grassley said. In 2006 ... the drug industry accounted for about 30 percent of the association’s $62.5 million in financing. One of the doctors named by Mr. Grassley is the association’s president-elect, Dr. Alan F. Schatzberg of Stanford, whose $4.8 million stock holdings in a drug development company raised the senator’s concern. Commercial arrangements are rampant throughout medicine. In the past two decades, drug and device makers have paid tens of thousands of doctors and researchers of all specialties. Worried that this money could taint doctors’ research plans or clinical judgment, government agencies, medical journals and universities have been forced to look more closely at deal details.

Note: For many powerful reports of corporate corruption, click here.

Chemical Law Has Global Impact
2008-06-12, Washington Post
http://www.washingtonpost.com/wp-dyn/content/article/2008/06/11/AR20080611035...

Europe this month rolled out new restrictions on makers of chemicals linked to cancer and other health problems, changes that are forcing U.S. industries to find new ways to produce a wide range of everyday products. The new laws in the European Union require companies to demonstrate that a chemical is safe before it enters commerce -- the opposite of policies in the United States, where regulators must prove that a chemical is harmful before it can be restricted or removed from the market. The changes come at a time when consumers are increasingly worried about the long-term consequences of chemical exposure and are agitating for more aggressive regulation. The European Union's tough stance on chemical regulation is the latest area in which the Europeans are reshaping business practices with demands that American companies either comply or lose access to a market of 27 countries and nearly 500 million people. From its crackdown on antitrust practices in the computer industry to its rigorous protection of consumer privacy, the European Union has adopted a regulatory philosophy that emphasizes the consumer. "There's a strong sense in Europe and the world at large that America is letting the market have a free ride," said Sheila Jasanoff, professor of science and technology studies at Harvard University's John F. Kennedy School of Government. "The Europeans believe . . . that being a good global citizen in an era of sustainability means you don't just charge ahead and destroy the planet without concern for what you're doing."

Note: For lots more on health issues from reliable, verifiable sources, click here.

Research Finds Wide Disparities in Health Care by Race and Region
2008-06-05, New York Times
http://www.nytimes.com/2008/06/05/health/research/05disparities.html?partner=...

Race and place of residence can have a staggering impact on the course and quality of the medical treatment a patient receives, according to new research showing that blacks with diabetes or vascular disease are nearly five times more likely than whites to have a leg amputated and that women in Mississippi are far less likely to have mammograms than those in Maine. The study, by researchers at Dartmouth, examined Medicare claims for evidence of racial and geographic disparities and found that on a variety of quality indices, blacks typically were less likely to receive recommended care than whites within a given region. But the most striking disparities were found from place to place. For instance, the widest racial gaps in mammogram rates within a state were in California and Illinois, with a difference of 12 percentage points between the white rate and the black rate. But the country’s lowest rate for blacks — 48 percent in California — was 24 percentage points below the highest rate — 72 percent in Massachusetts. The statistics were for women ages 65 to 69 who received screening in 2004 or 2005. In all but two states, black diabetics were less likely than whites to receive annual hemoglobin testing. But blacks in Colorado (66 percent) were far less likely to be screened than those in Massachusetts (88 percent). The study was commissioned by the nation’s largest health-related philanthropy, the Robert Wood Johnson Foundation, which on Thursday planned to announce a three-year, $300 million initiative intended to narrow health care disparities across lines of race and geography.

Note: For a treasure trove of important reports on health issues from reliable sources, click here.

EPA Scientists Decry Political Pressure
2008-04-23, CBS News/Associated Press
http://www.cbsnews.com/stories/2008/04/23/tech/main4037465.shtml

Hundreds of Environmental Protection Agency scientists complain they have been victims of political interference and pressure from superiors to skew their findings. The Union of Concerned Scientists said that more than half of the nearly 1,600 EPA staff scientists who responded online to a detailed questionnaire reported they had experienced incidents of political interference in their work. Francesca Grifo, director of the Union of Concerned Scientists' Scientific Integrity Program, said the survey results revealed "an agency in crisis" with low morale, especially among scientists involved in risk assessment and crafting regulations. "The investigation shows researchers are generally continuing to do their work, but their scientific findings are tossed aside when it comes time to write regulations," said Grifo. The group sent an online questionnaire to 5,500 EPA scientists and received 1,586 responses, a majority of them senior scientists who have worked for the agency for 10 years or more. The survey included chemists, toxicologists, engineers, geologists and experts in the life and environmental sciences. The report said that 60 percent of those responding, or 889 scientists, reported personally experiencing what they viewed as political interference in their work over the last five years. Senior managers and the White House Office of Management and Budget frequently second-guess scientific findings and change work conducted by EPA's scientists, the report said. Nearly 400 scientists said they had witnessed EPA officials misrepresenting scientific findings, 284 said they had [witnessed] the "selective or incomplete use of data to justify a specific regulatory outcome" and 224 scientists said they had been directed to "inappropriately exclude or alter technical information" in an EPA document.

Note: For a treasure trove of reports from reliable, verifiable sources on government corruption, click here.

VA stalling on care, judge told at S.F. trial
2008-04-21, San Francisco Chronicle (San Francisco's leading newspaper)
http://www.sfgate.com/cgi-bin/article.cgi?f=/c/a/2008/04/22/MNQK109AA7.DTL

More than 120 veterans of the wars in Afghanistan and Iraq commit suicide every week while the government stalls in granting returning troops the mental health treatment and benefits to which they are entitled, veterans advocates told a federal judge. The rights of hundreds of thousands of veterans are being violated by the Department of Veterans Affairs, "an agency that is in denial," and by a government health care system and appeals process for patients that is "broken down," Gordon Erspamer, lawyer for two advocacy groups, said in an opening statement at the trial of a nationwide lawsuit. He said veterans are committing suicide at the rate of 18 a day - a number acknowledged by a VA official in a Dec. 15 e-mail - and the agency's backlog of disability claims now exceeds 650,000, an increase of 200,000 since the Iraq war started in 2003. U.S. District Judge Samuel Conti ... ruled in January that the case could go to trial. In doing so, he rejected the government's argument that civil courts have no authority over the VA's medical decisions or how it handles grievances. If the advocates can prove their claims, Conti said in his ruling, they would show that "thousands of veterans, if not more, are suffering grievous injuries as the result of their inability to procure desperately needed and obviously deserved health care." He also ruled that veterans are legally entitled to five years of government-provided health care after leaving the service, despite federal officials' argument that they are required to provide only as much care as the VA's budget allows in a given year. The trial follows publication of a Rand study last week that estimated 300,000 U.S. troops returning from Afghanistan and Iraq, or 18.5 percent of the total, suffer from major depression or post-traumatic stress.

Note: For many reports from reliable, verifiable sources detailing the devastating impacts of modern war, click here. For a revealing commentary by a top U.S. general on how soldiers lives are ruined by needless wars, click here.

previous

12345678910...

next

· entire list